The PIM kinase inhibitor TP-3654 demonstrates efficacy in a murine model of myelofibrosis

被引：2

作者：

Dutta, Avik ^{[1
]}

Nath, Dipmoy ^{[1
]}

Yang, Yue ^{[1
]}

Mohi, Golam ^{[1
]}

机构：

[1] Univ Virginia, Charlottesville, VA USA

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-1874

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1874

引用

页数：2

共 50 条

[21] The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis
Can, Guray
Ayvaz, Suleyrnan
Can, Hatice
Karaboga, Ihsan
Demirtas, Selim
Aksit, Hasan
Yilmaz, Bulent
Korkmaz, Ugur
Kurt, Mevlut
Karaca, Turan
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (04) : 504 - 516
[22] Preclinical Efficacy of TGF-Beta Receptor I Kinase Inhibitor, Galunisertib, in Myelofibrosis
Yue, Lanzhu
Bartenstein, Matthias
Zhao, Wanke
Ho, Wan-Ting
Zhang, Ling
Rapaport, Franck
Levine, Ross L.
Shao, Zonghong
Zhao, Zhizhuang Joe
Verma, Amit
Epling-Burnette, Pearlie K
BLOOD, 2015, 126 (23)
[23] Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis
Koppikar, Priya
Abdel-Wahab, Omar
Hedvat, Cyrus
Marubayashi, Sachie
Patel, Jay
Goel, Aviva
Kucine, Nicole
Gardner, Jeffrey R.
Combs, Andrew P.
Vaddi, Kris
Haley, Patrick J.
Burn, Timothy C.
Rupar, Mark
Bromberg, Jacqueline F.
Heaney, Mark L.
de Stanchina, Elisa
Fridman, Jordan S.
Levine, Ross L.
BLOOD, 2010, 115 (14) : 2919 - 2927
[24] TAS8274, a Highly Selective Janus Kinase 3 Inhibitor, Demonstrates Potent Efficacy in an Animal Model of Rheumatoid Arthritis
Hayashi, Hiroaki
Harada, Takafumi
Demizu, Shunsuke
Tatsuzawa, Fumito
Sato, Ken
Mitsuya, Morihiro
Tanaka, Kenji
Yonekura, Kazuhiko
Utsugi, Teruhiro
Sasaki, Eiji
Iwasawa, Yoshikazu
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[25] The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus Disease
DeWald, Lisa Evans
Dyall, Julie
Sword, Jennifer M.
Torzewski, Lisa
Zhou, Huanying
Postnikova, Elena
Kollins, Erin
Alexander, Isis
Gross, Robin
Cong, Yu
Gerhardt, Dawn M.
Johnson, Reed F.
Olinger, Gene G., Jr.
Holbrook, Michael R.
Hensley, Lisa E.
Jahrling, Peter B.
JOURNAL OF INFECTIOUS DISEASES, 2018, 218 : S588 - S591
[26] TAS5315, a Novel Bruton's Tyrosine Kinase (BTK) Inhibitor, Demonstrates Potent Efficacy in an Animal Model of Rheumatoid Arthritis
Hosoi, Fumihito
Yoshiga, Youhei
Iguchi, Satoru
Kaneko, Ryuusuke
Nakachi, Yoshinori
Akasaka, Daichi
Yonekura, Kazuhiko
Utsugi, Teruhiro
Sasaki, Eiji
Iwasawa, Yoshikazu
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[27] Tofacitinib, a Janus Kinase Inhibitor Demonstrates Efficacy in an IL-15 Transgenic Mouse Model that Recapitulates Pathologic Manifestations of Celiac Disease
Yokoyama, Seiji
Perera, Pin-Yu
Waldmann, Thomas A.
Hiroi, Takachika
Perera, Liyanage P.
JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 (03) : 586 - 594
[28] The effect of janus kinase inhibitor on pruritus in an atopic dermatitis murine model
Yamamoto, Y.
Otsuka, A.
Nakashima, C.
Amano, W.
Tanimoto, A.
Hayashi, M.
Kabashima, K.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S92 - S92
[29] Discovery of selective small molecule Pan-Pim kinase inhibitors with potent oral efficacy in murine xenograft models
O'Brien, Sean
Haddach, Mustapha
Borsan, Cosmin
Michaux, Jerome
Kerdoncuff, Pauline
Schwaebe, Michael
Pierre, Fabrice
Stefan, Eric
Nedellec, Anne-Sophie
Siddiqui-Jain, Adam
Streiner, Nicole
Macalino, Diwata
Drygin, Denis
Ho, Caroline
Bliesath, Josh
Omori, May
Stansfield, Ryan
Phung, Jennifer
Ryckman, David
Rice, William
Anderes, Kenna
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
[30] Kinase inhibitor demonstrates efficacy in patient derived xenograft model of fibrolamellar hepatocellular carcinoma featuring DNAJB1-PRKACA gene fusion
Thatte, Jayant
Talaoc, Elvira C.
Scott, Colleen
Ren, Ken
Broudy, Thomas
CANCER RESEARCH, 2017, 77

← 1 2 3 4 5 →